We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
ALUNBRIG brigatinib 90 mg and 180 mg film-coated tablets blister pack, Takeda Pharmaceuticals Australia Pty Ltd, CON-895
Product name
ALUNBRIG brigatinib 90 mg and 180 mg film-coated tablets blister pack
Sponsor name
Takeda Pharmaceuticals Australia Pty Ltd
Batches
020846, 021779 and 022022
Consent start
Consent no.
CON-895
Duration
The consent is effective for the aforementioned batches only from 16 December 2021 until 31 January 2024.
Standard
Paragraph 8(1)(i) of Therapeutic Goods Order No. 91 – Standard for labels of prescription and related medicines (TGO 91)
Non-compliance with standard
The products do not conform with the requirements of paragraph 8(1)(i) of Therapeutic Goods Order No. 91 – Standard for labels of prescription and related medicines (TGO 91) in that the products do not include the current address of the sponsor.
Import, Supply, &/or Export
Supply
Therapeutic product type
Prescription medicines